Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Influenza [strain A/H5N1] vaccine 1 by GSK for Pandemic Influenza: Likelihood of Approval
Influenza [strain A/H5N1] vaccine 1 is under clinical development by GSK and currently in Phase II for Pandemic Influenza. According...
Data Insights
Influenza [strain A/H5N1] vaccine 1 by GSK for Influenza A Virus, H5N1 Subtype Infections: Likelihood of Approval
Influenza [strain A/H5N1] vaccine 1 is under clinical development by GSK and currently in Phase II for Influenza A Virus,...